Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Matrix Metalloproteinase 11
Imidazolines
Propionigenium
Examining the Relationship Between Delay Discounting, Delay Aversion, Diabetes Self-care Behaviors, and Diabetes Outcomes in U.S. Adults With Type 2 Diabetes.
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94.
View in:
PubMed
subject areas
Adrenergic Agents
Benzhydryl Compounds
Central Nervous System Stimulants
Cholinesterase Inhibitors
Cognition
Excitatory Amino Acid Agents
Humans
Neurotransmitter Agents
Nicotinic Agonists
Nootropic Agents
Substance-Related Disorders
authors with profiles
Kevin M Gray
Kathleen T. Brady
Bryan K. Tolliver